Related Experiment Videos
Vitamin D deficiency and hypocalcemia in an infant with newly diagnosed AML
Cathleen Cook1, Valeria Bernardo, John Shelso
1Departments of *Pediatric Hematology and Oncology §Oncology, St Jude Children's Research Hospital, Memphis, TN †Department of Pharmacy Practice, St Louis College of Pharmacy, St Louis, MO ‡Department of Pediatric Endocrinology, Sanford Children's Specialty Clinic, Sioux Falls, SD.
Insights
A 4-month-old infant with acute myeloid leukemia developed hypocalcemia after leukoreduction therapy. Addressing underlying vitamin D deficiency with cholecalciferol normalized calcium levels, highlighting its importance in pediatric leukemia care.
Area of Science:
- Pediatric Hematology Oncology
- Biochemistry
- Clinical Medicine
Background:
- Acute myeloid leukemia (AML) in infants presents unique challenges.
- Hyperleukocytosis is a common complication requiring prompt management.
- Leukoreduction therapy can lead to metabolic disturbances.
Observation:
- A 4-month-old male with AML and hyperleukocytosis underwent chemical leukoreduction.
- The patient developed symptomatic hypocalcemia following treatment.
- Serum calcium levels failed to normalize until vitamin D deficiency was identified and treated.
Findings:
- Low-dose cytarabine effectively reduced white blood cell count.
- Symptomatic hypocalcemia was directly linked to an underlying vitamin D deficiency.
- A single dose of cholecalciferol corrected the hypocalcemia within 48 hours.
Implications:
- Vitamin D deficiency should be considered in the differential diagnosis of prolonged hypocalcemia in infants with leukemia.
- Prompt management of vitamin D deficiency is crucial for normalizing calcium levels in pediatric cancer patients.
- This case underscores the importance of comprehensive metabolic evaluation and management in infants undergoing leukemia treatment.
Abstract:
We report a 4-month-old male presenting with hypocalcemia, hyperleukocytosis, and newly diagnosed acute myeloid leukemia. He received chemical leukoreduction through low-dosed cytarabine, with appropriate decrease in his white blood cell count and development of subsequent symptomatic hypocalcemia, which did not normalize until the underlying vitamin D deficiency was addressed. A single dose of cholecalciferol raised the serum calcium concentration to an appropriate level within 48 hours. For infants with newly diagnosed leukemia and prolonged hypocalcemia, vitamin D deficiency should be considered in the differential diagnosis and managed appropriately.
Related Concept Videos
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Skeleton and Calcium Homeostasis
Vitamins
Drug Dosing: Infants and Children
Role of Skin in Vitamin D Synthesis
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin D3(cholecalciferol).
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...